BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 37258604)

  • 1. Pilot evaluation of a single oral fecal microbiota transplantation for canine atopic dermatitis.
    Sugita K; Shima A; Takahashi K; Ishihara G; Kawano K; Ohmori K
    Sci Rep; 2023 May; 13(1):8824. PubMed ID: 37258604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between clinical efficacy on pruritus and serum interleukin-31 levels in dogs with atopic dermatitis treated with lokivetmab.
    Calesso JR; Marques VS; de Carvalho OV; Costa-Val AP
    Pol J Vet Sci; 2023 Jun; 26(2):231-238. PubMed ID: 37389418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal microbiota transplantation affects the recovery of AD-skin lesions and enhances gut microbiota homeostasis.
    Jiang X; Liu Z; Ma Y; Miao L; Zhao K; Wang D; Wang M; Ruan H; Xu F; Zhou Q; Xu S
    Int Immunopharmacol; 2023 May; 118():110005. PubMed ID: 36924566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporine decreases skin lesions and pruritus in dogs with atopic dermatitis: a blinded randomized prednisolone-controlled trial.
    Olivry T; Rivierre C; Jackson HA; Murphy KM; Davidson G; Sousa CA
    Vet Dermatol; 2002 Apr; 13(2):77-87. PubMed ID: 11972891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of serum Interleukin 34 (IL-34) and correlation with severity and pruritus scores in client-owned dogs with atopic dermatitis.
    Gow DJ; Jackson H; Forsythe P; Nuttall T; Gow AG; Mellanby RJ; Hume DA
    Vet Dermatol; 2020 Oct; 31(5):359-e94. PubMed ID: 32794277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the Canine Atopic Dermatitis Extent and Severity Index (CADESI)-4, a simplified severity scale for assessing skin lesions of atopic dermatitis in dogs.
    Olivry T; Saridomichelakis M; Nuttall T; Bensignor E; Griffin CE; Hill PB;
    Vet Dermatol; 2014 Apr; 25(2):77-85, e25. PubMed ID: 24461108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparable efficacy of a topical 0.0584% hydrocortisone aceponate spray and oral ciclosporin in treating canine atopic dermatitis.
    Nuttall TJ; McEwan NA; Bensignor E; Cornegliani L; Löwenstein C; Rème CA
    Vet Dermatol; 2012 Feb; 23(1):4-10, e1-2. PubMed ID: 21718368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic adipose-derived mesenchymal stem cell therapy in dogs with refractory atopic dermatitis: clinical efficacy and safety.
    Villatoro AJ; Hermida-Prieto M; Fernández V; Fariñas F; Alcoholado C; Rodríguez-García MI; Mariñas-Pardo L; Becerra J
    Vet Rec; 2018 Dec; 183(21):654. PubMed ID: 30158120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the early-life skin microbiota on the development of canine atopic dermatitis in a high-risk breed birth cohort.
    Rodriguez-Campos S; Rostaher A; Zwickl L; Fischer N; Brodard I; Vidal S; Brandt BW; Favrot C; Perreten V
    Sci Rep; 2020 Jan; 10(1):1044. PubMed ID: 31974513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs.
    Little PR; King VL; Davis KR; Cosgrove SB; Stegemann MR
    Vet Dermatol; 2015 Feb; 26(1):23-30, e7-8. PubMed ID: 25496303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of cutaneous and circulating (serum and exosomes) levels of chemokines (CCL17, CCL22, CCL27 and CCL28) in atopic dogs and their correlation with severity of the disease.
    Santoro D; Archer L; Chong E
    Vet Dermatol; 2022 Jun; 33(3):195-e56. PubMed ID: 35187733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbiota restoration through fecal microbiota transplantation: a new atopic dermatitis therapy.
    Kim JH; Kim K; Kim W
    Exp Mol Med; 2021 May; 53(5):907-916. PubMed ID: 34017060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of the Canine Atopic Dermatitis Lesion Index, a scale for the rapid scoring of lesion severity in canine atopic dermatitis.
    Plant JD; Gortel K; Kovalik M; Polissar NL; Neradilek MB
    Vet Dermatol; 2012 Dec; 23(6):515-e103. PubMed ID: 23140318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pilot evaluation of the antipruritic efficacy of a topical transient receptor potential melastatin subfamily 8 (TRPM8) agonist in dogs with atopic dermatitis and pedal pruritus.
    Tamamoto-Mochizuki C; Murphy KM; Olivry T
    Vet Dermatol; 2018 Feb; 29(1):29-e14. PubMed ID: 28952176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of CADESI-03 thresholds for increasing severity levels of canine atopic dermatitis.
    Olivry T; Mueller R; Nuttall T; Favrot C; Prélaud P;
    Vet Dermatol; 2008 Jun; 19(3):115-9. PubMed ID: 18477326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One dog's waste is another dog's wealth: A pilot study of fecal microbiota transplantation in dogs with acute hemorrhagic diarrhea syndrome.
    Gal A; Barko PC; Biggs PJ; Gedye KR; Midwinter AC; Williams DA; Burchell RK; Pazzi P
    PLoS One; 2021; 16(4):e0250344. PubMed ID: 33872339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A blinded, randomized, placebo-controlled, dose determination trial of lokivetmab (ZTS-00103289), a caninized, anti-canine IL-31 monoclonal antibody in client owned dogs with atopic dermatitis.
    Michels GM; Ramsey DS; Walsh KF; Martinon OM; Mahabir SP; Hoevers JD; Walters RR; Dunham SA
    Vet Dermatol; 2016 Dec; 27(6):478-e129. PubMed ID: 27647569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of an essential fatty acid-enriched diet in managing canine atopic dermatitis: a randomized, single-blinded, cross-over study.
    Bensignor E; Morgan DM; Nuttall T
    Vet Dermatol; 2008 Jun; 19(3):156-62. PubMed ID: 18477332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comprehensive analysis of gut and skin microbiota in canine atopic dermatitis in Shiba Inu dogs.
    Thomsen M; Künstner A; Wohlers I; Olbrich M; Lenfers T; Osumi T; Shimazaki Y; Nishifuji K; Ibrahim SM; Watson A; Busch H; Hirose M
    Microbiome; 2023 Oct; 11(1):232. PubMed ID: 37864204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical efficacy of fecal microbial transplantation treatment in adults with moderate-to-severe atopic dermatitis.
    Mashiah J; Karady T; Fliss-Isakov N; Sprecher E; Slodownik D; Artzi O; Samuelov L; Ellenbogen E; Godneva A; Segal E; Maharshak N
    Immun Inflamm Dis; 2022 Mar; 10(3):e570. PubMed ID: 34931478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.